Highly selective SYK inhibitor, GSK143, abrogates survival signals in chronic lymphocytic leukaemia. [electronic resource]
Producer: 20190716Description: 927-930 p. digitalISSN:- 1365-2141
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.